CANDEL THERAPEUTICS INC. - COMMON STOCK
6.6500
04-十月-24 14:59:57
15 分钟延时
股票
-0.0600
-0.89%
今日范围
6.4600 - 6.8800
ISIN
N/A
来源
NASDAQ
-
04 10月 2024 08:00:45 条件 Nasdaq GlobeNewswire
-
Candel Therapeutics to Present at H.C. Wainwright 26th Annual Global Investment Conference
03 9月 2024 07:00:00 条件 Nasdaq GlobeNewswire
-
Candel Therapeutics Reports Second Quarter 2024 Financial Results and Recent Corporate Highlights
13 8月 2024 07:00:01 条件 Nasdaq GlobeNewswire
-
18 6月 2024 07:00:00 条件 Nasdaq GlobeNewswire
-
Candel Therapeutics to Join Russell 3000® Index
11 6月 2024 07:00:00 条件 Nasdaq GlobeNewswire
-
FDA Grants Orphan Drug Designation for CAN-3110 for the Treatment of Recurrent High-Grade Glioma
30 5月 2024 07:00:00 条件 Nasdaq GlobeNewswire
-
Candel Therapeutics to Present at the Jefferies Global Healthcare Conference
22 5月 2024 07:00:00 条件 Nasdaq GlobeNewswire
-
20 5月 2024 07:00:00 条件 Nasdaq GlobeNewswire
-
Candel Therapeutics Reports First Quarter 2024 Financial Results and Recent Corporate Highlights
14 5月 2024 07:00:00 条件 Nasdaq GlobeNewswire
-
Candel Therapeutics Announces Upcoming Presentations at the 2024 ASCO Annual Meeting
25 4月 2024 07:00:00 条件 Nasdaq GlobeNewswire
-
11 4月 2024 08:00:00 条件 Nasdaq GlobeNewswire
-
09 4月 2024 07:00:00 条件 Nasdaq GlobeNewswire
-
04 4月 2024 07:00:00 条件 Nasdaq GlobeNewswire
-
28 3月 2024 07:05:47 条件 Nasdaq GlobeNewswire
-
05 3月 2024 15:30:00 条件 Nasdaq GlobeNewswire
-
CAN-3110 Receives FDA Fast Track Designation for Treatment of Recurrent High-Grade Glioma
13 2月 2024 06:30:00 条件 Nasdaq GlobeNewswire
-
05 2月 2024 07:00:00 条件 Nasdaq GlobeNewswire
-
Candel Therapeutics Receives FDA Fast Track Designation for CAN-2409 in Pancreatic Cancer
12 12月 2023 07:00:01 条件 Nasdaq GlobeNewswire
- <<
- <
- 1
- >